Abstract: An example electronic device includes a housing; a touchscreen display; a microphone; at least one speaker; a button disposed on a portion of the housing or set to be displayed on the touchscreen display; a wireless communication circuit; a processor; and a memory. When a user interface is not displayed on the touchscreen display, the electronic device enables a user to receive a user input through the button, receives user speech through the microphone, and then provides data on the user speech to an external server. An instruction for performing a task is received from the server. When the user interface is displayed on the touchscreen display, the electronic device enables the user to receive the user input through the button, receives user speech through the microphone, and then provides data on the user speech to the external server.

Abstract: A battery module includes: a battery cell assembly having a plurality of battery cells; a top plate configured to cover an upper side of the battery cell assembly; a bottom plate configured to cover a lower side of the battery cell assembly; a sensing assembly disposed to cover a front side and a rear side of the battery cell assembly; a pair of side plates disposed at side surfaces, respectively, of the battery cell assembly; and a pair of compression pads disposed between the pair of side plates and the battery cell assembly, respectively.

Abstract: The present disclosure relates to a nucleic acid analysis apparatus using a cartridge which can simplify the nucleic acid extraction and applicable to a molecular diagnostic POCT equipment. The nucleic acid analysis device includes a stage on which a cartridge is mountable, a nucleic acid extraction unit, and a control unit. The nucleic acid extraction unit performs a nucleic acid extraction through crushing of the sample, the cell disruption, and the nucleic acid purification as well as a nucleic acid amplification. The control unit controls the stage and the nucleic acid extraction unit so that the nucleic acid extraction through the crushing of the sample, the cell disruption, and the nucleic acid purification as well as the nucleic acid amplification are collectively performed.

Abstract: The present disclosure provides a cartridge for use in nucleic acid extraction and a nucleic acid extraction method which can simplify a nucleic acid extraction process and can be applicable to a point-of-care testing (POCT). The cartridge includes a chamber module, an air valve module, and a liquid valve module. The chamber module includes a plurality of chambers for extracting nucleic acids from a sample including a pretreatment chamber in which the sample is crushed and homogenization, cell disruption, and purification are performed. The air valve module is installed on the chamber module to control a pressure required to move a fluid between the plurality of chambers. The liquid valve module is installed below the chamber module to move the fluid between the plurality of chambers.

Abstract: The present disclosure provides a cartridge for use in nucleic acid extraction and a nucleic acid extraction method which can simplify a nucleic acid extraction process and can be applicable to a point-of-care testing (POCT). The cartridge includes a chamber module, an air valve module, and a liquid valve module. The chamber module includes a plurality of chambers for extracting nucleic acids from a sample including a pretreatment chamber in which the sample is crushed and homogenization, cell disruption, and purification are performed. The air valve module is installed on the chamber module to control a pressure required to move a fluid between the plurality of chambers. The liquid valve module is installed below the chamber module to move the fluid between the plurality of chambers.

Abstract: The present disclosure relates to a nucleic acid analysis apparatus using a cartridge which can simplify the nucleic acid extraction and applicable to a molecular diagnostic POCT equipment. The nucleic acid analysis device includes a stage on which a cartridge is mountable, a nucleic acid extraction unit, and a control unit. The nucleic acid extraction unit performs a nucleic acid extraction through crushing of the sample, the cell disruption, and the nucleic acid purification as well as a nucleic acid amplification. The control unit controls the stage and the nucleic acid extraction unit so that the nucleic acid extraction through the crushing of the sample, the cell disruption, and the nucleic acid purification as well as the nucleic acid amplification are collectively performed.

Abstract: Disclosed are a system and a method for precisely measuring a structure are disclosed. A reference meter installed at a fixed location provides GPS reference information. A plurality of response meters, respectively installed at a plurality of positions of the structure, acquire acceleration information through acceleration sensors and measure a plurality of real-time kinematic (RTK) displacement data based on the GPS reference information, respectively. The response meters synchronize acceleration information with the plurality of RTK displacement data measured to generate into a packet to be transmitted. An operation processor receives the acceleration information and the plurality of RTK displacement data and calculates structure response information. With the GPS and accelerometers, the dynamic behaviors of structures including high-rise buildings, bridges, dams, and harbors can be precisely measured.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.

Abstract: Disclosed are a system and a method for precisely measuring a structure are disclosed. A reference meter installed at a fixed location provides GPS reference information. A plurality of response meters, respectively installed at a plurality of positions of the structure, acquire acceleration information through acceleration sensors and measure a plurality of real-time kinematic (RTK) displacement data based on the GPS reference information, respectively. The response meters synchronize acceleration information with the plurality of RTK displacement data measured to generate into a packet to be transmitted. An operation processor receives the acceleration information and the plurality of RTK displacement data and calculates structure response information. With the GPS and accelerometers, the dynamic behaviors of structures including high-rise buildings, bridges, dams, and harbors can be precisely measured.

Abstract: A bio-sample pretreatment device according to an exemplary embodiment of the present invention includes a plurality of magnetism appliers disposed to be provided outside a prepared vessel and applying magnetism to the vessel, wherein magnetic poles of the magnetism appliers change.

Abstract: The present invention relates to a kit for simultaneous diagnosis of viral respiratory diseases. To be more specific, the present invention is directed to a method for diagnosing viral respiratory diseases by detecting the genes specific to the respiratory disease-causing virus, a primer set for diagnosing the viral respiratory diseases used in the diagnosis method, a composition for simultaneous diagnosis of viral respiratory diseases, comprising the primer set, and a kit for simultaneous diagnosis of viral respiratory diseases, comprising the composition. When the primer set of the present invention for diagnosing the viral respiratory diseases is used, 14 different types of respiratory viruses can be simultaneously detected only with one reaction through real-time multiplex reverse transcription (RT)-PCR, and the onset of respiratory diseases caused by these viruses can be diagnosed. Thus, the primer set of the present invention can be widely used for prompt diagnosis and treatment of respiratory diseases.

Abstract: Disclosed is a biomarker composition for diagnosing the toxicity of nanoparticles, which shows a change in expression by exposure to the nanoparticles, the biomarker composition comprising at least one gene selected from the group consisting of aldehyde dehydrogenase, glutamic-pyruvate transaminase, glutamate dehydrogenase, glutamicoxaloacetic transaminase, glutamic acid decarboxylase and glutamate-ammonia ligase, and to a method for evaluating the toxicity of nanoparticles using the same. The biomarker is a gene marker having a high correlation with the toxicity of nanoparticles, and the use of the biomarker can determine whether nanoparticles have toxicity, with high detection sensitivity. Also, the method is useful in monitoring or evaluating the toxicity of nanoparticles by analyzing factors having a high correlation with toxicity of nanoparticles.

Abstract: An electronic device is provided. The electronic device includes a processor, and a memory configured to store a messenger application, wherein the processor is configured to output the messenger application on the display and output a list of chat rooms joined based on a first user account on the display, and wherein the list of the plurality of chat rooms comprises a first chat room, in which the electronic device participates, and a second chat room in which another electronic device participates.

Abstract: The present invention relates to a kit for simultaneous diagnosis of viral respiratory diseases. To be more specific, the present invention is directed to a method for diagnosing viral respiratory diseases by detecting the genes specific to the respiratory disease-causing virus, a primer set for diagnosing the viral respiratory diseases used in the diagnosis method, a composition for simultaneous diagnosis of viral respiratory diseases, comprising the primer set, and a kit for simultaneous diagnosis of viral respiratory diseases, comprising the composition. When the primer set of the present invention for diagnosing the viral respiratory diseases is used, 14 different types of respiratory viruses can be simultaneously detected only with one reaction through real-time multiplex reverse transcription (RT)-PCR, and the onset of respiratory diseases caused by these viruses can be diagnosed. Thus, the primer set of the present invention can be widely used for prompt diagnosis and treatment of respiratory diseases.

Abstract: The present invention relates to a composition for detection of HCV by a single step reaction, comprising a specific primer and probe. In particular, the present invention relates to a composition for detection of HCV by a single step reaction, comprising the primer sequences of SEQ ID NOs:1 and 2; a composition for detection of HCV by a single step reaction, comprising both the primer sequences and a probe of SEQ ID NOs:5 or 9; a method for detecting HCV by a single step reaction, comprising the steps of obtaining a sample from a subject, and amplifying and detecting HCV using the primer and probe; and a kit comprising the primer and probe, in which the HCV detection method is characterized by a single step reaction.

Abstract: The present invention relates to a composition for detection of HCV by a single step reaction, comprising a specific primer and probe. In particular, the present invention relates to a composition for detection of HCV by a single step reaction, comprising the primer sequences of SEQ ID NOs:1 and 2; a composition for detection of HCV by a single step reaction, comprising both the primer sequences and a probe of SEQ ID NOs:5 or 9; a method for detecting HCV by a single step reaction, comprising the steps of obtaining a sample from a subject, and amplifying and detecting HCV using the primer and probe; and a kit comprising the primer and probe, in which the HCV detection method is characterized by a single step reaction.

Abstract: The present invention relates to a topical composition containing human epidermal growth factor (hEGF) and polyoxyethylene-polyoxypropylene copolymer having a viscosity of 4-10 cps at 37° C, 60 rpm as the base for topical formulation to improve the wound healing ability of hEGF.